- Home
- ZYME vs LSPD Comparison
ZYME vs LSPD Comparison
Compare ZYME & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | LSPD |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZYME | LSPD |
|---|---|---|
| Price | $25.80 | $11.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $28.50 | $13.63 |
| AVG Volume (30 Days) | ★ 1.8M | 454.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $134,481,000.00 | ★ $1,157,458,000.00 |
| Revenue This Year | $64.45 | $15.25 |
| Revenue Next Year | $67.04 | $11.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.21 | 14.24 |
| 52 Week Low | $9.03 | $7.34 |
| 52 Week High | $28.49 | $17.59 |
Technical Indicators
Market Signals| Indicator | ZYME | LSPD |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 51.78 |
| Support Level | $24.83 | $11.12 |
| Resistance Level | $27.49 | $11.45 |
| Average True Range (ATR) | 1.32 | 0.37 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 60.00 | 87.39 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.